Please login to the form below

Not currently logged in
Email:
Password:

Almirall

This page shows the latest Almirall news and features for those working in and with pharma, biotech and healthcare.

Sun Pharma passes milestone with novel psoriasis drug approval

Sun Pharma passes milestone with novel psoriasis drug approval

Last November, Sun Pharma’s European licensee for tildrakizumab - Spain’s Almirall - said it expects the launch of the drug in the EU to be delayed by at least six months ... Almirall licensed European rights to the drug in July 2016 and filed for

Latest news

More from news
Approximately 11 fully matching, plus 67 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2017 Deal Watch March 2017

    12. Symatese. Almirall. Development collaboration. Customised products in aesthetics. 8. AgaImmune.

  • Deal Watch December 2016 Deal Watch December 2016

    510. Nuevolution (Denmark). Almirall (Spain). Research collaboration. RORγt inhibitors for inflammatory skin diseases and psoriatic arthritis. ... $21m plus $80m equity. Biosimilars. Nuevolution. Almirall. $453m. $11.8m. Inhibitors to transcription

  • Deal Watch October 2016 Deal Watch October 2016

    $575m. $198m. 2.9. Respiratory 2014. Almirall. Products pipeline. $2, 100 milestones.

  • Deal Watch July 2016 Deal Watch July 2016

    Celyad. $311m. $12.5m. Almirall. Patagonia. $28m. $3.5m. Petra Pharma. Sprint BioScience. ... Almirall's initial expenditure has been a more modest $3.5m for this earlier stage product.

  • Stronger together Stronger together

    Also speaking at the eyeforpharma conference was Almirall's CEO Eduardo Sanchiz, who noted that, while patient-centricity is often talked about in the industry, “ we have difficulties putting it in

More from intelligence
Approximately 2 fully matching, plus 10 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Solaris Health

    Abbvie. Aimmune. Almirall. Ascensia. BD. Bio-Medical Research. Desitin. Ferring. Flexyfoot. Gedeon Richter.

  • HAVAS LYNX

    AbbVie. Alexion. Almirall. Astellas. AstraZeneca. Bayer. Eisai. Genzyme. Janssen. Kowa. Lilly.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics